231 related articles for article (PubMed ID: 15968408)
1. Double heterozygosity for Factor V Leiden and Factor V Cambridge mutations associated with low levels of activated protein C resistance in a Spanish thrombophilic family.
Santamaría A; Soria JM; Tirado I; Mateo J; Coll I; Souto JC; Fontcuberta J
Thromb Haemost; 2005 Jun; 93(6):1193-5. PubMed ID: 15968408
[No Abstract] [Full Text] [Related]
2. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
DeSancho MT; Berlus N; Christos PJ; Rand J
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
[TBL] [Abstract][Full Text] [Related]
4. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
5. In the presence of other inherited or acquired high-risk situations, the FV Cambridge mutation may be an additional thrombophilic risk factor, through its effect on APC sensitivity.
Santacroce R; Bossone A; Brancaccio V; Fortina P; Margaglione M
Thromb Haemost; 2000 Jun; 83(6):963-4. PubMed ID: 10896257
[No Abstract] [Full Text] [Related]
6. Usefulness of thrombophilia testing in venous thromboembolic disease: findings from the RIETE registry.
Gabriel F; Portolés O; Labiós M; Rodríguez C; Cisneros E; Vela J; Nuñez M;
Clin Appl Thromb Hemost; 2013; 19(1):42-7. PubMed ID: 22327823
[TBL] [Abstract][Full Text] [Related]
7. Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs.
Legnani C; Cini M; Cosmi B; Filippini M; Favaretto E; Palareti G
Thromb Haemost; 2014 Jun; 111(6):1194-6. PubMed ID: 24500135
[No Abstract] [Full Text] [Related]
8. Inherited Thrombophilia in a Lebanese Family of Four Generations: A Case Report of Recurrent Miscarriage.
Khalife S; Bissar-Tadmouri N
Vasc Health Risk Manag; 2020; 16():53-56. PubMed ID: 32021228
[TBL] [Abstract][Full Text] [Related]
9. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
[TBL] [Abstract][Full Text] [Related]
10. Upper extremity deep vein thrombosis in a young patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
Vayá A; Todolí J; Ricart J; Estellés T; Mira Y; Villa P; Calabuig JR; Aznar J
Clin Appl Thromb Hemost; 2001 Jan; 7(1):72-4. PubMed ID: 11190909
[TBL] [Abstract][Full Text] [Related]
11. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
12. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Gessoni G; Valverde S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
[TBL] [Abstract][Full Text] [Related]
14. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
15. Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers.
Morange PE; Aillaud MF; Nicaud V; Henry M; Juhan-Vague I
Thromb Haemost; 2001 Dec; 86(6):1583-4. PubMed ID: 11776333
[No Abstract] [Full Text] [Related]
16. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.
De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G
Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848
[TBL] [Abstract][Full Text] [Related]
17. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
Reitsma PH; van de Stolpe A
Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden--the commonest molecular defect in arterial and venous thrombophilia in India.
Ahmed RP; Gupta PK; Kannan M; Choudhry VP; Saxena R
Thromb Res; 2003 Apr; 110(1):19-21. PubMed ID: 12877904
[No Abstract] [Full Text] [Related]
19. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
20. [Hemostasis-related risk profile in venous thrombosis].
Hach-Wunderle V
Internist (Berl); 2002 Jan; 43(1):10-5. PubMed ID: 11963740
[No Abstract] [Full Text] [Related]
[Next] [New Search]
